STOCKSCREENR

MSLE

NASDAQ

Satellos Bioscience Inc. Common Stock

$7.95+0.68(+9.35%)Mkt Cap: $10.24M

Key Stats

Market Cap

$10.24M

P/E Ratio

-4.68

EPS

$-1.70

Dividend Yield

0.00%

52-Week Range

$4.52 — $13.39

Volume

46.25K

Avg Volume

82.50K

Beta

1.08

Price Alerts for MSLE

Get alerted when MSLE hits your target price.

$

Free — enter your email to get started

Valuation

P/E (TTM)

-4.68

Forward P/E

—

PEG Ratio

-0.02

P/S (TTM)

0.00

P/B (TTM)

0.49

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

-0.51%

ROA (TTM)

-0.26%

ROIC

—

Gross Margin

0.00%

Operating Margin

0.00%

Net Margin

—

Debt/Equity

0.00

Current Ratio

11.13

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

—

EPS Growth (5Y)

—

Sales Growth (3Y)

—

Sales Growth (5Y)

—

EPS Est (This Year)

$-1.58

EPS Est (Next Year)

$-1.72

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

—

Frequency

—

Ex-Dividend Date

—

Cash/Share

$1.11

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

1.29M

Float

1.06M

Free Float %

82.59%

About

Sector

Healthcare

Industry

Medical - Pharmaceuticals

Country

CA

Exchange

NASDAQ

IPO Date

2024-05-10

Employees

14

CEO

Francis Gleeson

Index Membership

—

Website

http://www.satellos.com

Satellos Bioscience Inc. Common Stock (MSLE) is a healthcare company in the medical - pharmaceuticals industry listed on the NASDAQ. With a market capitalization of $10.24M, a P/E ratio of -4.68, MSLE is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare MSLE against other stocks using dozens of fundamental and technical filters.

Similar Stocks

SDEV

Stablecoin Development Corp.

$1.24

-2.36%

$33.02M

KYNB

Kyntra Bio, Inc.

$7.27

+3.12%

$29.42M

0QFK.L

Celyad Oncology S.A.

$0.17

+2.94%

$4.83M

0IL8.L

Kyntra Bio, Inc.

$7.23

+2.40%

$29.21M

0HIY.L

Atara Biotherapeutics, Inc.

$4.99

+8.54%

$40.84M

0N4A.L

Vivesto AB

$0.08

+0.97%

$43.74M

Frequently Asked Questions

What is Satellos Bioscience Inc. Common Stock's P/E ratio?

Satellos Bioscience Inc. Common Stock (MSLE) has a trailing twelve-month (TTM) P/E ratio of -4.68. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Satellos Bioscience Inc. Common Stock pay a dividend?

No, Satellos Bioscience Inc. Common Stock (MSLE) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Satellos Bioscience Inc. Common Stock's market cap?

Satellos Bioscience Inc. Common Stock (MSLE) has a market capitalization of $10.24 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.